Definitive Healthcare Corp. (DH) stock plummeted by 9.6% in Monday's intraday trading session, following a price target cut by analysts at Deutsche Bank.
According to a research note from Deutsche Bank, the bank lowered its price target on Definitive Healthcare shares from $5 to $4, while maintaining a "Hold" rating on the stock.
The price target reduction reflects analysts' concerns about the company's prospects and future performance, which contributed to the sharp sell-off in Definitive Healthcare's stock price on Monday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。